Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients

BACKGROUND: To evaluate the safety of besifloxacin ophthalmic suspension 0.6% when used in laser-assisted in situ keratomileusis (LASIK) prophylactic antibiotic regimens. METHODS: Retrospective surveillance of LASIK surgery cases where besifloxacin ophthalmic suspension 0.6% or moxifloxacin ophthalm...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Steven A, McDonald, Marguerite B, Majmudar, Parag A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552478/
https://www.ncbi.nlm.nih.gov/pubmed/23355771
http://dx.doi.org/10.2147/OPTH.S38279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552478/
https://www.ncbi.nlm.nih.gov/pubmed/23355771
http://dx.doi.org/10.2147/OPTH.S38279

Ejemplares similares